ZPHC Retatrutide AQ pen 30 mg

ZPHC Retatrutide AQ pen 30 mg — Advanced weight loss support

This investigational medicine works on three pathways to reduce appetite, increase fullness, and boost your metabolism—leading to meaningful weight loss.

How it works

Triple action: Acts on GLP-1, GIP, and GCGR pathways to reduce hunger, increase satiety, and boost energy burn for effective weight loss.

Your dosing schedule

• Start low: 2.5–5 mg per week to minimize stomach upset
• Target dose: 5–10 mg per week (10 mg when tolerated)
• Treatment length: 12–24 weeks, depending on your response

How to take it: One injection under the skin, once a week. Follow sterile technique and storage instructions.

What to expect

Common side effects: Nausea, vomiting, diarrhea, constipation, reduced appetite. Usually improve as your body adjusts. Eat small meals and stay hydrated.

Serious (rare): Severe belly pain, gallbladder problems, fast heartbeat. Stop immediately and contact your doctor.

Not for you if: Pregnant, breastfeeding, or have medullary thyroid cancer or MEN2 history.

Getting started

• Medical review — Confirm it’s safe and right for you
• Baseline tests — Weight, blood sugar, and other labs
• Ongoing support — Regular check-ins, dose adjustments, and lifestyle guidance

We recommend using a peptide dosage and reconstitution calculator to determine how many pens you’ll need for your cycle.